human rhinoviru harv remain lead caps sever disease include common cold despite consider research last year develop effect vaccine view mani unless due part antigen diver circus harv natur antigen distinct type current known span three spec b c early attempt develop shown inactive capable serv strong immunogen induce neutral antibody yet limit virus prepare recovery continue identify variant list challenge pertain prepare polyval magnitude require true efficacy rhinovirus continue prove aunt challenge review describe biology past present advance design 